Draft legislation details European Union (EU) plans to cut back its COVID-19 vaccine exports; the Biden administration announces a 3-month extension to Affordable Care Act (ACA) open enrollment; Johnson & Johnson (J&J) may not meet its March 31 vaccine delivery deadline.
Despite facing a third COVID-19 surge, the European Union has drafted legislation that will cut back its export of COVID-19 vaccines manufactured among member countries for 6 weeks, The New York Times reported. The 3 vaccines approved in the European Union—Pfizer/BioNTech, Moderna, and AstraZeneca—could all be affected, with AstraZeneca reportedly being the main target following its decision in January to reduce its vaccine supply by more than half. Meanwhile, the legislation also proposes blocking shipments to countries with higher vaccination rates than the European Union.
Following its previous announcement of a February 15 to May 15 special open enrollment period for HealthCare.gov marketplace plans among the 36 states that have expanded Medicaid coverage, the Biden administration is extending enrollment through August 15, The Hill reported. Current plan enrollees will be allowed to continue to change their plans, although doing so could reset their cost-sharing limits to $0, meaning more out-of-pocket expenses. In the first 2 weeks alone of the original extension, more than 200,000 Americans enrolled in plans.
Having promised to deliver 20 million doses of its single-shot COVID-19 vaccine to the federal government by month’s end, early numbers are showing Johnson & Johnson (J&J) may fall short of meeting this goal, according to Politico. Only 20%, or 4 million doses, have reportedly been delivered to the government thus far, while 4.6 million have been distributed to states and federal vaccine programs. The news follows an Emergency Use Authorization from the FDA that will permit a Catalent Pharma plant in Bloomington, Indiana, to produce and ship vaccines for J&J.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More